United States Biotechnology & Medical Research

Travere Therapeutics, Inc. (TVTX)

Travere Therapeutics experienced significant insider trading activity over the past ninety days, characterized by sixty-five sell transactions totaling approximately 161 million dollars. Executives, including CEO Eric Dube, executed numerous planned divestments. These sales occurred following a recent earnings report that missed expectations, while the stock price remains down 8.3 percent during this period.
Ticker: TVTX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Travere Therapeutics, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.7
Dube Eric M CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
69.98
Quantity 53,763 +1.2%
Value US$1,114,787
2.7
Dube Eric M CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
303.94
Quantity 39,943 +10.8%
Value US$195,840
2.7
Dube Eric M CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
283.69
Quantity 1,555 -21.2%
Value US$886,284
2.7
ERIC DUBE Director; Officer Executive Director
Transaction date
Proposed sale
Price
53.27
Quantity 243,735
Value US$12,983,763
2.8
Heerma Peter EVP, CHIEF COMMERCIAL OFFICER Officer
Transaction date
Planned sale
Price
65.07
Quantity 8,282 -6.6%
Value US$538,917
2.7
Dube Eric M CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
64.95
Quantity 6,802 -1.5%
Value US$441,795
2.7
Dube Eric M CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
64.59
Quantity 101,691 -18.8%
Value US$6,567,876
2.7
ERIC DUBE Director; Officer Executive Director
Transaction date
Proposed sale
Price
63.48
Quantity 108,493
Value US$6,887,136
2.8
PETER HEERMA Officer Officer
Transaction date
Proposed sale
Price
63.48
Quantity 8,282
Value US$525,741
2.3
ROTE WILLIAM E. Chief Research Officer Officer
Transaction date
Planned sale
Price
63.61
Quantity 47,746 -32.7%
Value US$3,037,247
2.3
ROTE WILLIAM E. Chief Research Officer Officer
Transaction date
Planned sale
Price
63.12
Quantity 65,104 -30.8%
Value US$4,109,397
2.8
Heerma Peter EVP, CHIEF COMMERCIAL OFFICER Officer
Transaction date
Planned sale
Price
63.65
Quantity 79,113 -40.3%
Value US$5,035,906
2.8
Heerma Peter EVP, CHIEF COMMERCIAL OFFICER Officer
Transaction date
Planned sale
Price
63.25
Quantity 93,604 -32.3%
Value US$5,920,182
2.7
Dube Eric M CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
63.64
Quantity 96,125 -18.2%
Value US$6,117,289
2.7
Dube Eric M CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
63.26
Quantity 99,716 -15.9%
Value US$6,307,964
2.7
ERIC DUBE Director; Officer Executive Director
Transaction date
Proposed sale
Price
62.51
Quantity 195,841
Value US$12,242,021
2.3
WILLIAM ROTE Officer Officer
Transaction date
Proposed sale
Price
62.51
Quantity 112,850
Value US$7,054,254
2.8
PETER HEERMA Officer Officer
Transaction date
Proposed sale
Price
62.51
Quantity 172,717
Value US$10,796,540
2.3
ROTE WILLIAM E. Chief Research Officer Officer
Transaction date
Planned sale
Price
65.31
Quantity 270 -0.3%
Value US$17,634
2.3
ROTE WILLIAM E. Chief Research Officer Officer
Transaction date
Planned sale
Price
63.65
Quantity 3,000 -3.0%
Value US$190,952
2.3
ROTE WILLIAM E. Chief Research Officer Officer
Transaction date
Planned sale
Price
62.66
Quantity 29,021 -22.2%
Value US$1,818,317
2.3
ROTE WILLIAM E. Chief Research Officer Officer
Transaction date
Planned sale
Price
61.99
Quantity 63,907 -32.9%
Value US$3,961,851
2.8
Heerma Peter EVP, CHIEF COMMERCIAL OFFICER Officer
Transaction date
Planned sale
Price
65.31
Quantity 1,431 -1.2%
Value US$93,458
2.8
Heerma Peter EVP, CHIEF COMMERCIAL OFFICER Officer
Transaction date
Planned sale
Price
63.65
Quantity 1,400 -1.2%
Value US$89,113
2.8
Heerma Peter EVP, CHIEF COMMERCIAL OFFICER Officer
Transaction date
Planned sale
Price
62.59
Quantity 27,421 -18.6%
Value US$1,716,379
2.8
Heerma Peter EVP, CHIEF COMMERCIAL OFFICER Officer
Transaction date
Planned sale
Price
62.05
Quantity 71,938 -32.8%
Value US$4,463,875
2.7
Inrig Jula EVP, Head of R&D & CMO Officer
Transaction date
Planned sale
Price
65.31
Quantity 400 -0.4%
Value US$26,124
2.7
Inrig Jula EVP, Head of R&D & CMO Officer
Transaction date
Planned sale
Price
63.69
Quantity 1,600 -1.6%
Value US$101,896
2.7
Inrig Jula EVP, Head of R&D & CMO Officer
Transaction date
Planned sale
Price
62.62
Quantity 17,284 -14.4%
Value US$1,082,397
2.7
Inrig Jula EVP, Head of R&D & CMO Officer
Transaction date
Planned sale
Price
62.02
Quantity 25,390 -17.5%
Value US$1,574,604
2.5
REED ELIZABETH E Chief Legal Officer and GC Officer
Transaction date
Planned sale
Price
65.31
Quantity 300 -0.3%
Value US$19,593
2.5
REED ELIZABETH E Chief Legal Officer and GC Officer
Transaction date
Planned sale
Price
63.69
Quantity 1,400 -1.3%
Value US$89,166
2.5
REED ELIZABETH E Chief Legal Officer and GC Officer
Transaction date
Planned sale
Price
62.63
Quantity 13,874 -11.5%
Value US$868,965
2.5
REED ELIZABETH E Chief Legal Officer and GC Officer
Transaction date
Planned sale
Price
62.03
Quantity 21,926 -15.3%
Value US$1,359,971
2.7
Dube Eric M CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
65.31
Quantity 270 -0.1%
Value US$17,634
2.7
Dube Eric M CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
63.64
Quantity 3,102 -0.7%
Value US$197,422
2.7
Dube Eric M CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
62.66
Quantity 28,796 -6.2%
Value US$1,804,222
2.7
Dube Eric M CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
61.99
Quantity 63,498 -12.0%
Value US$3,936,527
2.7
Cline Christopher R. CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
65.31
Quantity 400 -0.5%
Value US$26,124
2.7
Cline Christopher R. CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
63.69
Quantity 1,900 -2.1%
Value US$121,004
2.7
Cline Christopher R. CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
62.61
Quantity 20,735 -18.8%
Value US$1,298,175
2.7
Cline Christopher R. CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
62.00
Quantity 27,473 -19.9%
Value US$1,703,241
2.9
Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Officer
Transaction date
Planned sale
Price
63.66
Quantity 300 -0.7%
Value US$19,099
2.9
Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Officer
Transaction date
Planned sale
Price
62.85
Quantity 800 -1.8%
Value US$50,278
2.9
Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Officer
Transaction date
Planned sale
Price
62.14
Quantity 4,275 -9.0%
Value US$265,627
2.5
ELIZABETH REED Officer Officer
Transaction date
Proposed sale
Price
65.79
Quantity 39,576
Value US$2,603,705
2.9
SANDRA CALVIN Officer Officer
Transaction date
Proposed sale
Price
65.79
Quantity 5,375
Value US$353,621
2.7
CHRISTOPHER CLINE Officer Officer
Transaction date
Proposed sale
Price
65.79
Quantity 50,508
Value US$3,322,921
2.8
PETER HEERMA Officer Officer
Transaction date
Proposed sale
Price
65.79
Quantity 102,190
Value US$6,723,080
2.7
ERIC DUBE Director; Officer Executive Director
Transaction date
Proposed sale
Price
65.79
Quantity 95,666
Value US$6,293,866
2.3
WILLIAM ROTE Officer Officer
Transaction date
Proposed sale
Price
65.79
Quantity 96,198
Value US$6,328,866
2.7
JULA INRIG Officer Officer
Transaction date
Proposed sale
Price
65.79
Quantity 44,674
Value US$2,939,102
1.9
Meckler Jeffrey A Non-Executive Director
Transaction date
Planned sale
Price
68.09
Quantity 3,100 -3.3%
Value US$211,073
1.9
Meckler Jeffrey A Non-Executive Director
Transaction date
Planned sale
Price
67.46
Quantity 14,000 -12.9%
Value US$944,488
1.9
Meckler Jeffrey A Non-Executive Director
Transaction date
Planned sale
Price
66.15
Quantity 1,200 -1.1%
Value US$79,380
1.9
Meckler Jeffrey A Non-Executive Director
Transaction date
Planned sale
Price
65.39
Quantity 1,700 -1.5%
Value US$111,166
1.9
JEFFREY MECKLER Director Non-Executive Director
Transaction date
Proposed sale
Price
66.22
Quantity 20,000
Value US$1,324,400
2.7
Cline Christopher R. CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
66.37
Quantity 642 -0.5%
Value US$42,610
2.2
LYONS GARY A Non-Executive Director
Transaction date
Planned sale
Price
63.86
Quantity 900 -1.4%
Value US$57,470
2.2
LYONS GARY A Non-Executive Director
Transaction date
Planned sale
Price
63.27
Quantity 4,100 -6.2%
Value US$259,390
2.2
GARY LYONS Director Non-Executive Director
Transaction date
Proposed sale
Price
63.53
Quantity 5,000
Value US$317,650
2.2
LYONS GARY A Non-Executive Director
Transaction date
Planned sale
Price
64.16
Quantity 500 -0.8%
Value US$32,081
2.2
LYONS GARY A Non-Executive Director
Transaction date
Planned sale
Price
63.50
Quantity 2,600 -4.0%
Value US$165,100
2.2
LYONS GARY A Non-Executive Director
Transaction date
Planned sale
Price
62.53
Quantity 1,900 -2.9%
Value US$118,805
2.2
GARY A LYONS Director Non-Executive Director
Transaction date
Proposed sale
Price
62.14
Quantity 5,000
Value US$310,700
2.3
Coughlin Timothy Non-Executive Director
Transaction date
Planned sale
Price
50.07
Quantity 10,000 -15.1%
Value US$500,747
0.5
Baynes Roy D. Non-Executive Director
Transaction date
Planned sale
Price
50.00
Quantity 4,500 -9.8%
Value US$225,000
0.5
ROY BAYNES Director Non-Executive Director
Transaction date
Proposed sale
Price
50.00
Quantity 4,500
Value US$225,000
2.3
Coughlin Timothy Director Non-Executive Director
Transaction date
Proposed sale
Price
50.04
Quantity 10,000
Value US$500,430
2.3
Coughlin Timothy Non-Executive Director
Transaction date
Planned sale
Price
43.49
Quantity 3,250 -5.9%
Value US$141,342
2.3
Coughlin Timothy Director Non-Executive Director
Transaction date
Proposed sale
Price
43.44
Quantity 3,250
Value US$141,183
2.7
Dube Eric M CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
43.95
Quantity 22,500 -4.9%
Value US$988,875
2.3
ROTE WILLIAM E. Chief Research Officer Officer
Transaction date
Planned sale
Price
43.95
Quantity 2,763 -2.3%
Value US$121,434
2.7
Inrig Jula CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
43.95
Quantity 311 -0.3%
Value US$13,668
2.7
Cline Christopher R. CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
43.95
Quantity 310 -0.3%
Value US$13,624
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-19 2026-10-15 PlS Planned sale
2.7
Dube Eric M

CHIEF EXECUTIVE OFFICER

Executive Director
53,763 +1.2%
69.98
US$1,114,787 		53,763 +1.2% 69.98 US$1,114,787
2026-10-19 2026-10-15 PlS Planned sale
2.7
Dube Eric M

CHIEF EXECUTIVE OFFICER

Executive Director
39,943 +10.8%
303.94
US$195,840 		39,943 +10.8% 303.94 US$195,840
2026-10-19 2026-10-15 PlS Planned sale
2.7
Dube Eric M

CHIEF EXECUTIVE OFFICER

Executive Director
1,555 -21.2%
283.69
US$886,284 		1,555 -21.2% 283.69 US$886,284
2026-10-15 2026-10-15 PrS Proposed sale
2.7
ERIC DUBE

Director; Officer

Executive Director
243,735
53.27
US$12,983,763 		243,735 53.27 US$12,983,763
2026-09-17 2026-09-17 PlS Planned sale
2.8
Heerma Peter

EVP, CHIEF COMMERCIAL OFFICER

Officer
8,282 -6.6%
65.07
US$538,917 		8,282 -6.6% 65.07 US$538,917
2026-09-17 2026-09-17 PlS Planned sale
2.7
Dube Eric M

CHIEF EXECUTIVE OFFICER

Executive Director
6,802 -1.5%
64.95
US$441,795 		6,802 -1.5% 64.95 US$441,795
2026-09-17 2026-09-17 PlS Planned sale
2.7
Dube Eric M

CHIEF EXECUTIVE OFFICER

Executive Director
101,691 -18.8%
64.59
US$6,567,876 		101,691 -18.8% 64.59 US$6,567,876
2026-09-17 2026-09-17 PrS Proposed sale
2.7
ERIC DUBE

Director; Officer

Executive Director
108,493
63.48
US$6,887,136 		108,493 63.48 US$6,887,136
2026-09-17 2026-09-17 PrS Proposed sale
2.8
PETER HEERMA

Officer

Officer
8,282
63.48
US$525,741 		8,282 63.48 US$525,741
2026-09-17 2026-09-16 PlS Planned sale
2.3
ROTE WILLIAM E.

Chief Research Officer

Officer
47,746 -32.7%
63.61
US$3,037,247 		47,746 -32.7% 63.61 US$3,037,247
2026-09-17 2026-09-16 PlS Planned sale
2.3
ROTE WILLIAM E.

Chief Research Officer

Officer
65,104 -30.8%
63.12
US$4,109,397 		65,104 -30.8% 63.12 US$4,109,397
2026-09-17 2026-09-16 PlS Planned sale
2.8
Heerma Peter

EVP, CHIEF COMMERCIAL OFFICER

Officer
79,113 -40.3%
63.65
US$5,035,906 		79,113 -40.3% 63.65 US$5,035,906
2026-09-17 2026-09-16 PlS Planned sale
2.8
Heerma Peter

EVP, CHIEF COMMERCIAL OFFICER

Officer
93,604 -32.3%
63.25
US$5,920,182 		93,604 -32.3% 63.25 US$5,920,182
2026-09-17 2026-09-16 PlS Planned sale
2.7
Dube Eric M

CHIEF EXECUTIVE OFFICER

Executive Director
96,125 -18.2%
63.64
US$6,117,289 		96,125 -18.2% 63.64 US$6,117,289
2026-09-17 2026-09-16 PlS Planned sale
2.7
Dube Eric M

CHIEF EXECUTIVE OFFICER

Executive Director
99,716 -15.9%
63.26
US$6,307,964 		99,716 -15.9% 63.26 US$6,307,964
2026-09-16 2026-09-16 PrS Proposed sale
2.7
ERIC DUBE

Director; Officer

Executive Director
195,841
62.51
US$12,242,021 		195,841 62.51 US$12,242,021
2026-09-16 2026-09-16 PrS Proposed sale
2.3
WILLIAM ROTE

Officer

Officer
112,850
62.51
US$7,054,254 		112,850 62.51 US$7,054,254
2026-09-16 2026-09-16 PrS Proposed sale
2.8
PETER HEERMA

Officer

Officer
172,717
62.51
US$10,796,540 		172,717 62.51 US$10,796,540
2026-09-17 2026-09-15 PlS Planned sale
2.3
ROTE WILLIAM E.

Chief Research Officer

Officer
270 -0.3%
65.31
US$17,634 		270 -0.3% 65.31 US$17,634
2026-09-17 2026-09-15 PlS Planned sale
2.3
ROTE WILLIAM E.

Chief Research Officer

Officer
3,000 -3.0%
63.65
US$190,952 		3,000 -3.0% 63.65 US$190,952
2026-09-17 2026-09-15 PlS Planned sale
2.3
ROTE WILLIAM E.

Chief Research Officer

Officer
29,021 -22.2%
62.66
US$1,818,317 		29,021 -22.2% 62.66 US$1,818,317
2026-09-17 2026-09-15 PlS Planned sale
2.3
ROTE WILLIAM E.

Chief Research Officer

Officer
63,907 -32.9%
61.99
US$3,961,851 		63,907 -32.9% 61.99 US$3,961,851
2026-09-17 2026-09-15 PlS Planned sale
2.8
Heerma Peter

EVP, CHIEF COMMERCIAL OFFICER

Officer
1,431 -1.2%
65.31
US$93,458 		1,431 -1.2% 65.31 US$93,458
2026-09-17 2026-09-15 PlS Planned sale
2.8
Heerma Peter

EVP, CHIEF COMMERCIAL OFFICER

Officer
1,400 -1.2%
63.65
US$89,113 		1,400 -1.2% 63.65 US$89,113
2026-09-17 2026-09-15 PlS Planned sale
2.8
Heerma Peter

EVP, CHIEF COMMERCIAL OFFICER

Officer
27,421 -18.6%
62.59
US$1,716,379 		27,421 -18.6% 62.59 US$1,716,379
2026-09-17 2026-09-15 PlS Planned sale
2.8
Heerma Peter

EVP, CHIEF COMMERCIAL OFFICER

Officer
71,938 -32.8%
62.05
US$4,463,875 		71,938 -32.8% 62.05 US$4,463,875
2026-09-17 2026-09-15 PlS Planned sale
2.7
Inrig Jula

EVP, Head of R&D & CMO

Officer
400 -0.4%
65.31
US$26,124 		400 -0.4% 65.31 US$26,124
2026-09-17 2026-09-15 PlS Planned sale
2.7
Inrig Jula

EVP, Head of R&D & CMO

Officer
1,600 -1.6%
63.69
US$101,896 		1,600 -1.6% 63.69 US$101,896
2026-09-17 2026-09-15 PlS Planned sale
2.7
Inrig Jula

EVP, Head of R&D & CMO

Officer
17,284 -14.4%
62.62
US$1,082,397 		17,284 -14.4% 62.62 US$1,082,397
2026-09-17 2026-09-15 PlS Planned sale
2.7
Inrig Jula

EVP, Head of R&D & CMO

Officer
25,390 -17.5%
62.02
US$1,574,604 		25,390 -17.5% 62.02 US$1,574,604
2026-09-17 2026-09-15 PlS Planned sale
2.5
REED ELIZABETH E

Chief Legal Officer and GC

Officer
300 -0.3%
65.31
US$19,593 		300 -0.3% 65.31 US$19,593
2026-09-17 2026-09-15 PlS Planned sale
2.5
REED ELIZABETH E

Chief Legal Officer and GC

Officer
1,400 -1.3%
63.69
US$89,166 		1,400 -1.3% 63.69 US$89,166
2026-09-17 2026-09-15 PlS Planned sale
2.5
REED ELIZABETH E

Chief Legal Officer and GC

Officer
13,874 -11.5%
62.63
US$868,965 		13,874 -11.5% 62.63 US$868,965
2026-09-17 2026-09-15 PlS Planned sale
2.5
REED ELIZABETH E

Chief Legal Officer and GC

Officer
21,926 -15.3%
62.03
US$1,359,971 		21,926 -15.3% 62.03 US$1,359,971
2026-09-17 2026-09-15 PlS Planned sale
2.7
Dube Eric M

CHIEF EXECUTIVE OFFICER

Executive Director
270 -0.1%
65.31
US$17,634 		270 -0.1% 65.31 US$17,634
2026-09-17 2026-09-15 PlS Planned sale
2.7
Dube Eric M

CHIEF EXECUTIVE OFFICER

Executive Director
3,102 -0.7%
63.64
US$197,422 		3,102 -0.7% 63.64 US$197,422
2026-09-17 2026-09-15 PlS Planned sale
2.7
Dube Eric M

CHIEF EXECUTIVE OFFICER

Executive Director
28,796 -6.2%
62.66
US$1,804,222 		28,796 -6.2% 62.66 US$1,804,222
2026-09-17 2026-09-15 PlS Planned sale
2.7
Dube Eric M

CHIEF EXECUTIVE OFFICER

Executive Director
63,498 -12.0%
61.99
US$3,936,527 		63,498 -12.0% 61.99 US$3,936,527
2026-09-17 2026-09-15 PlS Planned sale
2.7
Cline Christopher R.

CHIEF FINANCIAL OFFICER

Officer
400 -0.5%
65.31
US$26,124 		400 -0.5% 65.31 US$26,124
2026-09-17 2026-09-15 PlS Planned sale
2.7
Cline Christopher R.

CHIEF FINANCIAL OFFICER

Officer
1,900 -2.1%
63.69
US$121,004 		1,900 -2.1% 63.69 US$121,004
2026-09-17 2026-09-15 PlS Planned sale
2.7
Cline Christopher R.

CHIEF FINANCIAL OFFICER

Officer
20,735 -18.8%
62.61
US$1,298,175 		20,735 -18.8% 62.61 US$1,298,175
2026-09-17 2026-09-15 PlS Planned sale
2.7
Cline Christopher R.

CHIEF FINANCIAL OFFICER

Officer
27,473 -19.9%
62.00
US$1,703,241 		27,473 -19.9% 62.00 US$1,703,241
2026-09-17 2026-09-15 PlS Planned sale
2.9
Calvin Sandra

SVP, CHIEF ACCOUNTING OFFICER

Officer
300 -0.7%
63.66
US$19,099 		300 -0.7% 63.66 US$19,099
2026-09-17 2026-09-15 PlS Planned sale
2.9
Calvin Sandra

SVP, CHIEF ACCOUNTING OFFICER

Officer
800 -1.8%
62.85
US$50,278 		800 -1.8% 62.85 US$50,278
2026-09-17 2026-09-15 PlS Planned sale
2.9
Calvin Sandra

SVP, CHIEF ACCOUNTING OFFICER

Officer
4,275 -9.0%
62.14
US$265,627 		4,275 -9.0% 62.14 US$265,627
2026-09-15 2026-09-15 PrS Proposed sale
2.5
ELIZABETH REED

Officer

Officer
39,576
65.79
US$2,603,705 		39,576 65.79 US$2,603,705
2026-09-15 2026-09-15 PrS Proposed sale
2.9
SANDRA CALVIN

Officer

Officer
5,375
65.79
US$353,621 		5,375 65.79 US$353,621
2026-09-15 2026-09-15 PrS Proposed sale
2.7
CHRISTOPHER CLINE

Officer

Officer
50,508
65.79
US$3,322,921 		50,508 65.79 US$3,322,921
2026-09-15 2026-09-15 PrS Proposed sale
2.8
PETER HEERMA

Officer

Officer
102,190
65.79
US$6,723,080 		102,190 65.79 US$6,723,080
2026-09-15 2026-09-15 PrS Proposed sale
2.7
ERIC DUBE

Director; Officer

Executive Director
95,666
65.79
US$6,293,866 		95,666 65.79 US$6,293,866
2026-09-15 2026-09-15 PrS Proposed sale
2.3
WILLIAM ROTE

Officer

Officer
96,198
65.79
US$6,328,866 		96,198 65.79 US$6,328,866
2026-09-15 2026-09-15 PrS Proposed sale
2.7
JULA INRIG

Officer

Officer
44,674
65.79
US$2,939,102 		44,674 65.79 US$2,939,102
2026-09-11 2026-09-10 PlS Planned sale
1.9
Meckler Jeffrey A
Non-Executive Director
3,100 -3.3%
68.09
US$211,073 		3,100 -3.3% 68.09 US$211,073
2026-09-11 2026-09-10 PlS Planned sale
1.9
Meckler Jeffrey A
Non-Executive Director
14,000 -12.9%
67.46
US$944,488 		14,000 -12.9% 67.46 US$944,488
2026-09-11 2026-09-10 PlS Planned sale
1.9
Meckler Jeffrey A
Non-Executive Director
1,200 -1.1%
66.15
US$79,380 		1,200 -1.1% 66.15 US$79,380
2026-09-11 2026-09-10 PlS Planned sale
1.9
Meckler Jeffrey A
Non-Executive Director
1,700 -1.5%
65.39
US$111,166 		1,700 -1.5% 65.39 US$111,166
2026-09-10 2026-09-10 PrS Proposed sale
1.9
JEFFREY MECKLER

Director

Non-Executive Director
20,000
66.22
US$1,324,400 		20,000 66.22 US$1,324,400
2026-09-03 2026-09-02 S Sale
2.7
Cline Christopher R.

CHIEF FINANCIAL OFFICER

Officer
642 -0.5%
66.37
US$42,610 		642 -0.5% 66.37 US$42,610
2026-08-19 2026-08-18 PlS Planned sale
2.2
LYONS GARY A
Non-Executive Director
900 -1.4%
63.86
US$57,470 		900 -1.4% 63.86 US$57,470
2026-08-19 2026-08-18 PlS Planned sale
2.2
LYONS GARY A
Non-Executive Director
4,100 -6.2%
63.27
US$259,390 		4,100 -6.2% 63.27 US$259,390
2026-08-18 2026-08-18 PrS Proposed sale
2.2
GARY LYONS

Director

Non-Executive Director
5,000
63.53
US$317,650 		5,000 63.53 US$317,650
2026-08-19 2026-08-17 PlS Planned sale
2.2
LYONS GARY A
Non-Executive Director
500 -0.8%
64.16
US$32,081 		500 -0.8% 64.16 US$32,081
2026-08-19 2026-08-17 PlS Planned sale
2.2
LYONS GARY A
Non-Executive Director
2,600 -4.0%
63.50
US$165,100 		2,600 -4.0% 63.50 US$165,100
2026-08-19 2026-08-17 PlS Planned sale
2.2
LYONS GARY A
Non-Executive Director
1,900 -2.9%
62.53
US$118,805 		1,900 -2.9% 62.53 US$118,805
2026-08-17 2026-08-17 PrS Proposed sale
2.2
GARY A LYONS

Director

Non-Executive Director
5,000
62.14
US$310,700 		5,000 62.14 US$310,700
2026-06-16 2026-06-12 PlS Planned sale
2.3
Coughlin Timothy
Non-Executive Director
10,000 -15.1%
50.07
US$500,747 		10,000 -15.1% 50.07 US$500,747
2026-06-16 2026-06-12 PlS Planned sale
0.5
Baynes Roy D.
Non-Executive Director
4,500 -9.8%
50.00
US$225,000 		4,500 -9.8% 50.00 US$225,000
2026-06-12 2026-06-12 PrS Proposed sale
0.5
ROY BAYNES

Director

Non-Executive Director
4,500
50.00
US$225,000 		4,500 50.00 US$225,000
2026-06-12 2026-06-12 PrS Proposed sale
2.3
Coughlin Timothy

Director

Non-Executive Director
10,000
50.04
US$500,430 		10,000 50.04 US$500,430
2026-05-19 2026-05-15 PlS Planned sale
2.3
Coughlin Timothy
Non-Executive Director
3,250 -5.9%
43.49
US$141,342 		3,250 -5.9% 43.49 US$141,342
2026-05-15 2026-05-15 PrS Proposed sale
2.3
Coughlin Timothy

Director

Non-Executive Director
3,250
43.44
US$141,183 		3,250 43.44 US$141,183
2026-05-06 2026-05-06 PlS Planned sale
2.7
Dube Eric M

CHIEF EXECUTIVE OFFICER

Executive Director
22,500 -4.9%
43.95
US$988,875 		22,500 -4.9% 43.95 US$988,875
2026-05-06 2026-05-06 PlS Planned sale
2.3
ROTE WILLIAM E.

Chief Research Officer

Officer
2,763 -2.3%
43.95
US$121,434 		2,763 -2.3% 43.95 US$121,434
2026-05-06 2026-05-06 PlS Planned sale
2.7
Inrig Jula

CHIEF MEDICAL OFFICER

Officer
311 -0.3%
43.95
US$13,668 		311 -0.3% 43.95 US$13,668
2026-05-06 2026-05-06 PlS Planned sale
2.7
Cline Christopher R.

CHIEF FINANCIAL OFFICER

Officer
310 -0.3%
43.95
US$13,624 		310 -0.3% 43.95 US$13,624

See older Travere Therapeutics, Inc. insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Travere Therapeutics, Inc. history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Travere Therapeutics, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America